When: Price $208-210 if 200 SMA ($197) not under threat

Then: Add second tranche

When: $200-205 zone ONLY if 200 SMA holds on retest with bullish reversal candle

Then: Aggressive accumulation if underweight

HOLD - maintain current position sizing discipline, add only on weakness below $215 with explicit hedging into November earnings

• Forward P/E of 14.4x is not a 'gift' but embeds the most optimistic consensus estimates; a beta of 2.22 means any earnings miss can deflate the multiple to 18-20x, causing a 20-30% drawdown
• Macro environment (97% probability of zero Fed cuts in 2026, 10-year above 5%) is structurally hostile to long-duration growth assets; the aggressive analyst treats this as a 2027 problem, but it's a near-term risk
• Working capital deterioration is real: AR growing 21 percentage points faster than revenue indicates DSO deterioration; concentrated in four hyperscaler customers creates correlated credit and demand risk
• Technical picture shows caution not confirmation: price range-bound $222-$231, volume declining to 86.85M vs 120M+ typical, RSI at 55.85 with MACD barely positive indicating momentum stall
• Trump-Xi tariff binary is asymmetric: 31% benign probability suggests 3-5% upside but escalatory scenario with export controls could cause 10-15% gap down plus multiple compression
• Sentiment at 6.2/10 reflects anxious mild bullishness, not disbelief; clients showing $91k realized losses are looking for reasons to sell rather than accumulating conviction positions
• Adding above $225 directly contradicts the trader's plan; a $208 stop creates $17/share (7.5%) risk, and stacking 3% tranches can build 60-70 basis points of unintended concentration risk

→ vs aggressive: 14.4x forward P/E is not 'a gift' but embeds the most optimistic consensus estimates; with 2.22 beta, any Q3 FY26 miss versus consensus could deflate the multiple from 14.4x to 18-20x, causing 20-30% drawdown before narrative shift

→ vs aggressive: Duration versus earnings growth math assumes upward earnings revisions; if hyperscaler capex pauses, Anthropic IPO creates narrative peak, or sovereign AI deals lag, revisions go negative and you get simultaneous multiple compression AND earnings cuts

→ vs aggressive: Working capital dismissal ignores AR growing 21pp faster than revenue; concentrated hyperscaler receivables create correlated credit and demand risk, and not having had a collection problem yet is precisely why you shouldn't add into the setup that would expose you to the first one

→ vs aggressive: Technical 'textbook continuation' framing ignores range-bound action ($222-$231), declining volume (86.85M vs 120M+ typical), and momentum stall (RSI 55.85, MACD barely positive) that looks more like quiet distribution than accumulation

→ vs aggressive: Trump-Xi tariff binary asymmetry is terrible: 3-5% upside in benign outcome vs 10-15% gap down plus multiple compression in escalatory outcome; deferring exposure until after resolution is basic event risk management, not hiding

→ vs aggressive: Sentiment at 6.2/10 is not 'disbelief' but anxious mild bullishness; $51B AI investments portfolio is hidden correlated leverage during multiple compression, not a moat in a drawdown

→ vs aggressive: Adding above $225 directly contradicts the trader's plan; the $208 stop creates $17/share risk, and stacking 3% tranches can build 60-70bps of concentration risk on a name that 'was a gift'

Maintain current weight, implement 10-20% hedge via collar (if at target) or put spread (if underweight), scale in tranches of 2-3% of portfolio at 210-215, no adds above 225, and re-evaluate post-Trump-Xi summit and Q3 print.

• Forward P/E of 14.4x embeds specific assumptions about hyperscaler capex, gross margins holding above 74%, and clean Blackwell ramp—none guaranteed
• AR growth running 21 percentage points faster than revenue reflects correlated credit and demand risk with a four-name customer concentration
• 51 billion dollar investment portfolio in AI ecosystem partners represents correlated leverage, not optionality, in a drawdown
• Technical setup is constructive: price above all major MAs, MACD positive with expanding histogram, RSI at 55.85 not overbought
• September 14 low at 208.47 tagged lower Bollinger band and was immediately bought; recovery retraced ~85% of prior leg
• 10 EMA at 222.43 held on the most recent pullback, which was only 86 million volume on below-average activity—not distribution
• Polymarket modal tariff expectation is 5-15% band at 31% probability; benign resolution likely produces 3-5% relief, escalatory outcome 10-15% gap
• 5% underperformance 'insurance premium' is expensive when underlying earnings compound at 100%+ annually and positive catalyst could produce 15-20% rally
• Conservative analyst's trailing stop to 10 EMA at 222.43 and tightening to 50 SMA at 215.19 is sound but should include breakout rule at 230.10 on 130M volume
• Sentiment reading of 6.2/10 mildly bullish reflects a market correctly priced for binary uncertainty, not a coiled spring or air pocket

→ vs aggressive: Forward earnings estimates are consensus guesses, not facts—14.4x multiple could compress to 20x, not 16x, if consensus proves too optimistic given beta of -2.22

→ vs aggressive: Working capital warnings dismissed as stylistic choice are actually 21pp AR-to-revenue divergence reflecting correlated credit and demand risk across four hyperscaler customers

→ vs aggressive: 51B investment portfolio is correlated leverage in a drawdown, not strategic optionality—the framing conflates diversification with de-correlation

→ vs aggressive: Chasing exposure above 225 before the Trump-Xi resolution ignores expected value asymmetry where escalatory outcome produces 10-15% gap versus 3-5% relief

→ vs conservative: 86M volume on most recent session was below-average and occurred after a five-session 211-229 rally—this is consolidation, not quiet distribution

→ vs conservative: RSI at 55.85 and price above all major MAs with MACD histogram expanding represents intact trend, not warning—lower Bollinger band at 208.47 held as support

→ vs conservative: 5% underperformance 'insurance premium' is excessive when earnings compound at 100%+ annually and positive catalyst could yield 15-20% upside—insurance premium exceeds expected loss

→ vs conservative: SOX pullback after six-day rally is calendar effect, not bearish thesis—distinguishing cyclical noise from structural signals is essential